Shotlee LogoShotlee
Blog
Download on theApp Store
Become aBeta Tester
Skip to main content
Tamannaah Bhatia Addresses Ozempic Rumors and Struggles with Inflammation - Featured image
Entertainment

Tamannaah Bhatia Addresses Ozempic Rumors and Struggles with Inflammation

Actress Tamannaah Bhatia has spoken out about rumors surrounding her weight and addressed her struggles with inflammation. She emphasized the changing nature of a woman's body and the importance of embracing natural curves.

Shotlee·November 10, 2025·Updated Jan 27, 2026·2 min read
Share:

Tamannaah Bhatia on Ozempic Rumors and Inflammation Struggles

Tamannaah Bhatia recently discussed how she has always been naturally slim, especially during her younger years. Speaking with Harper's Bazaar India, she noted that having been in front of the camera since she was 15, her physical changes have been visible to the public. She stated that until her late 20s, she maintained a slender physique, which she considers her natural body type.

The actress revealed, however, that she struggled to manage her weight during the COVID pandemic, a period when she believes the Hindi-speaking audience formed their current perception of her. Before entering Bollywood, Tamannaah had already established herself in South Indian cinema. Her role in S. S. Rajamouli's Baahubali: The Beginning (2015) significantly boosted her nationwide recognition.

According to Tamannaah, while this might be a new experience for the Hindi-speaking viewers, she has nearly 100 films to her name, showcasing her in various physical forms, predominantly leaner ones. She emphasized the importance of acknowledging that a woman's body undergoes constant changes, presenting a different version of itself roughly every five years.

Tamannaah further explained that maintaining her weight proved challenging during the pandemic. "For me, Covid hit my body hard, making it tough to maintain the weight I had in my 20s. I battled with it. I enjoy eating rice, roti, and dal."

Track your medication journey

Join thousands using Shotlee to track GLP-1 medications.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Become aBeta Tester

She continued, noting that despite adopting healthy habits, she still had to face the camera. She began to feel self-conscious about her size and constantly tried to correct it. Health tracking apps like Shotlee can help monitor these changes and provide insights into managing weight and inflammation. She became concerned about her protruding tummy and questioned what was happening with her body.

Dealing with Inflammation

Tamannaah further elaborated on the impact of inflammation and her strategies for managing it. She stated that inflammation is a genuine concern, and any woman experiencing hormonal cycles understands the shifts within her body. She experienced similar changes in her early 30s and acknowledges that her curves are a natural part of her physique.

She concluded by saying that her body shape is inherent to her Sindhi heritage, emphasizing that her hip and waist structure are permanent features. Tamannaah expressed her belief that she would never conform to global beauty standards, advocating for the celebration of Indian beauty and the appreciation of natural curves.

Original source: mid-day

View original article →
#Tamannaah Bhatia#Ozempic#inflammation#weight#body image#Bollywood#South Indian cinema
  1. Home
  2. Blog
  3. Tamannaah Bhatia Addresses Ozempic Rumors and Struggles with Inflammation

Related Articles

Millennial Stars Admit to Ozempic & GLP-1 Use: Transformations
GLP-1 Medications

Millennial Stars Admit to Ozempic & GLP-1 Use: Transformations

Midlife weight gain is hitting millennial stars hard, but many are turning to Ozempic and other GLP-1s for help. Celebrities including Amy Schumer, Golnesa 'GG' Gharachedaghi, and Serena Williams have openly admitted to using these medications, sharing their triumphs, side effects, and transformations. Discover their stories and the science behind these popular drugs.

SNAC in Ozempic and Wegovy Tablets Raises Gut Health Questions, Study Finds
GLP-1 Medications

SNAC in Ozempic and Wegovy Tablets Raises Gut Health Questions, Study Finds

New research uncovers potential effects of SNAC—the hidden ingredient enabling Ozempic and Wegovy tablets—on gut health. In a 21-day animal study, repeated exposure led to shifts in harmful gut bacteria, elevated inflammation, and depleted cognitive proteins. While not proving harm in humans, findings urge caution as oral semaglutide use surges.

73M Overweight Urban Indians, GLP-1 Awareness <5%: Kantar Report
Metabolic Health

73M Overweight Urban Indians, GLP-1 Awareness <5%: Kantar Report

Urban India faces a metabolic crisis with 73 million overweight adults, yet GLP-1 therapy awareness hovers below 5%, per Kantar's latest report. Despite high weight loss intent, a stark knowledge gap limits adoption of these diabetes and obesity treatments. Explore the data, demographics, and paths forward for better metabolic health.

Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Get Started

Resources

  • Health Blog
  • Support Center
  • System Status

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with ♥ for the community